Exposure to worm infection in the womb cuts eczema risk
Exposure to worm infections in the womb may protect newborn infant from developing eczema.
Washington: A new study has suggested that exposure to worm infections in the womb may protect a newborn infant from developing eczema.
The research supports the so-called ``hygiene hypothesis``, which proposes that exposure to infections in early childhood can modify the immune system and protect the child from allergies later in life.
A preliminary study carried out at the MRC/UVRI Uganda Research Unit on AIDS in Entebbe, Uganda, in 2005 showed a reduced risk of eczema among infants whose mothers had worms and suggested an increased incidence among infants of mothers who received albendazole-a commonly used drug to treat worm infection-during pregnancy compared to infants whose mothers received a placebo.
In a follow-up study, researchers carried out a randomised, double-blind trial on 2,507 pregnant women in Uganda, comparing those treated with either albendazole or a second drug, praziquantel, against those administered a placebo, and looking at how this affected their offspring``s risk of developing eczema.
Harriet Mpairwe, first author of the new study, said, "Worm infections can adversely affect a person``s health, but the evidence also suggests that exposure to infection early in a child``s life can have a beneficial effect in terms of modifying its immune system and protecting against allergies. We wanted to examine in a large cohort what effect de-worming women during pregnancy has on their offspring."
The findings have been published in the journal Pediatric Allergy and Immunology.